Wen-Jing Ding

Wen-Jing Ding

Auto-generated profile, based on publicly available information

Wen-Jing Ding

Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China; Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University, Jinan, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
WDWen-Jing Ding
Wen-Jing Ding
XLXue-Hui Li
Xue-Hui Li
CTCong-Min Tang
Cong-Min Tang
XYXue-Chun Yang
Xue-Chun Yang
YSYan Sun
Yan Sun
YXYan-qiu Xing
Yan-qiu Xing
AMP-activated protein kinase alpha 2 (AMPKα2) regulates energy metabolism, protein synthesis, and glucolipid metabolism myocardial cells. Ketone bodies produced by fatty acid β-oxidation, especially β-hydroxybutyrate, are fatty energy-supplying substances for the heart, brain, and other organs during fasting and long-term exercise. They also regulate metabolic signaling for multiple cellular functions. Lysine β-hydroxybutyrylation (Kbhb) is a β-hydroxybutyrate-mediated protein posttranslational modification. Histone Kbhb has been identified in yeast, mouse, and human cells. However, whether AMPK regulates protein Kbhb is yet unclear. Hence, the present study explored the changes in proteomics and Kbhb modification omics in the hearts of AMPKα2 knockout mice using a comprehensive quantitative proteomic analysis. Based on mass spectrometry (LC-MS/MS) analysis, the number of 1181 Kbhb modified sites in 455 proteins were quantified between AMPKα2 knockout mice and wildtype mice; 244 Kbhb sites in 142 proteins decreased or increased after AMPKα2 knockout (fold change >1.5 or <1/1.5, p < 0.05). The regulation of Kbhb sites in 26 key enzymes of fatty acid degradation and tricarboxylic acid cycle was noted in AMPKα2 knockout mouse cardiomyocytes. These findings, for the first time, identified proteomic features and Kbhb modification of cardiomyocytes after AMPKα2 knockout, suggesting that AMPKα2 regulates energy metabolism by modifying protein Kbhb.

15 October 2026 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
XLXuehui Li
Xuehui Li
WDWenjing Ding
Wenjing Ding
XYXuechun Yang
Xuechun Yang
CTCongmin Tang
Congmin Tang
WYWenzhuo Yu
Wenzhuo Yu
YXYan-qiu Xing
Yan-qiu Xing
Cardiac aging is characterized by progressive functional decline and metabolic remodeling. We previously found that lysine β-hydroxybutyrylation (Kbhb) is altered in wild-type (WT) aged and AMP-activated protein kinase alpha 2 (AMPKα2)-knockout (AK) young hearts, but whether this landscape can be reversed therapeutically remains unknown. We evaluated the therapeutic potential of human umbilical cord mesenchymal stromal cell-derived exosomes (hUCMSC-exos) in WT and AK aged mice, using young and aged untreated cohorts as controls. Quantitative proteomics across six experimental groups identified 1,755 Kbhb sites on 652 proteins, mapping the dynamic cardiac Kbhb landscape under aging, AMPKα2 deficiency, and exosome intervention. In wild-type aged (WTA) mice, hUCMSC-exos improved systolic and diastolic function, enhanced grip strength, reduced fibrosis, and restored ATP levels, accompanied by predominant downregulation of Kbhb on enzymes of glycolysis/gluconeogenesis, fatty acid oxidation, the tricarboxylic acid cycle, and oxidative phosphorylation. In AMPKα2-knockout aged (AKA) mice, exosomes partially improved mitochondrial ultrastructure and diastolic indices but did not rescue systolic function or fibrosis. Site-level analysis revealed that exosomes selectively normalized Kbhb sites elevated during aging, whereas AMPKα2 deficiency caused nonselective global depletion. The candidate AMPKα2-SIRT3 pathway, supported by SIRT5, may underlie this Kbhb reprogramming. We validated carnitine acetyltransferase (CRAT) K141bhb as an age-accumulated modification reversed by exosomes in an AMPKα2- associated manner. Molecular modeling indicated that K141bhb neutralizes the positive charge of K141, disrupting the local salt bridge between K141 and E144 and destabilizing the α-helical structure, suggesting that K141bhb may serve as a metabolic brake on CRAT activity. These findings map the cardiac Kbhb landscape and show that hUCMSC-exos ameliorate cardiac aging through AMPKα2- associated Kbhb modulation.